The DOAC edoxaban can replace dalteparin for treating cancer patients with venous thromboembolism.
The chain patented new tech to help better manage oncolytic usage.
Hurdles to adoption of biosimilars include regulatory issues and lack of interchangeability with the reference drugs.
Pharmacists need to stay informed about new technologies in order to help diabetic patients take advantage.
New study finds just how much people like and trust their pharmacists.
Research finds that pharmacists in ACOs improve medication use (and save money).
Easy-to-swallow bits of information from around the world of pharmacy.
Will healthcare manufacturing in Puerto Rico be back on its feet by next hurricane season?
Pharmacy chains are stepping up to help diabetes patients.
New plans are designed around feedback and a desire to increase safety checks.